[{"address1": "170 Harbor Way", "address2": "Suite 300", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 550 3500", "fax": "650 871 8580", "website": "https://vaxart.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Mr. Steven  Lo", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 751398, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sean N. Tucker Ph.D.", "age": 56, "title": "Senior VP & Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 622439, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James F. Cummings M.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 679943, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Phillip Eric  Lee", "age": 36, "title": "CFO, Principal Financial Officer & Principal Accounting Officer", "yearBorn": 1988, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raymond D. Stapleton Jr., Ph.D.", "age": 52, "title": "Chief Technology Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edward B. Berg", "age": 59, "title": "Senior VP & General Counsel", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Laurie  Hastings", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shaily Jaini Garg", "title": "Senior Vice President of Clinical Development & Project Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rajesh  Kapoor Ph.D.", "title": "Senior Vice President of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 6, "overallRisk": 9, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://newsroom.biotapharma.com/", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.3144, "open": 0.3217, "dayLow": 0.3175, "dayHigh": 0.3599, "regularMarketPreviousClose": 0.3144, "regularMarketOpen": 0.3217, "regularMarketDayLow": 0.3175, "regularMarketDayHigh": 0.3599, "exDividendDate": 1352419200, "payoutRatio": 0.0, "beta": 1.573, "forwardPE": -0.8687805, "volume": 953905, "regularMarketVolume": 953905, "averageVolume": 1838776, "averageVolume10days": 2467900, "averageDailyVolume10Day": 2467900, "bid": 0.2512, "ask": 0.42, "bidSize": 2, "askSize": 2, "marketCap": 81195432, "fiftyTwoWeekLow": 0.28, "fiftyTwoWeekHigh": 1.07, "priceToSalesTrailing12Months": 2.8291092, "fiftyDayAverage": 0.5366, "twoHundredDayAverage": 0.68485, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 48265920, "profitMargins": -2.33268, "floatShares": 210871288, "sharesOutstanding": 227948992, "sharesShort": 12229363, "sharesShortPriorMonth": 11353052, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.053600002, "heldPercentInsiders": 0.00865, "heldPercentInstitutions": 0.15732001, "shortRatio": 5.4, "shortPercentOfFloat": 0.0542, "impliedSharesOutstanding": 227948992, "bookValue": 0.259, "priceToBook": 1.3752896, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -66948000, "trailingEps": -0.33, "forwardEps": -0.41, "lastSplitFactor": "1:11", "lastSplitDate": 1518566400, "enterpriseToRevenue": 1.682, "enterpriseToEbitda": -0.84, "52WeekChange": -0.6043956, "SandP52WeekChange": 0.059571505, "lastDividendValue": 12.188, "lastDividendDate": 1352419200, "quoteType": "EQUITY", "currentPrice": 0.3562, "targetHighPrice": 8.0, "targetLowPrice": 2.0, "targetMeanPrice": 4.66667, "targetMedianPrice": 4.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 51723000, "totalCashPerShare": 0.227, "ebitda": -57443000, "totalDebt": 23284000, "quickRatio": 0.701, "currentRatio": 0.751, "totalRevenue": 28700000, "debtToEquity": 39.515, "revenuePerShare": 0.142, "returnOnAssets": -0.32091, "returnOnEquity": -1.14706, "grossProfits": -45513000, "freeCashflow": 42317248, "operatingCashflow": -44764000, "revenueGrowth": 3.68, "grossMargins": -1.58582, "ebitdaMargins": -2.0015, "operatingMargins": -0.7568, "financialCurrency": "USD", "symbol": "VXRT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "hasPrePostMarketData": true, "fiftyTwoWeekLowChange": 0.07620001, "fiftyTwoWeekLowChangePercent": 0.2721429, "fiftyTwoWeekRange": "0.28 - 1.07", "fiftyTwoWeekHighChange": -0.7138001, "fiftyTwoWeekHighChangePercent": -0.6671028, "fiftyTwoWeekChangePercent": -60.439564, "dividendDate": 1518566400, "earningsTimestamp": 1742500860, "earningsTimestampStart": 1747080000, "earningsTimestampEnd": 1747425600, "earningsCallTimestampStart": 1742502600, "earningsCallTimestampEnd": 1742502600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.33, "epsForward": -0.41, "epsCurrentYear": -0.335, "priceEpsCurrentYear": -1.0632836, "fiftyDayAverageChange": -0.18039998, "fiftyDayAverageChangePercent": -0.33619082, "twoHundredDayAverageChange": -0.32864997, "twoHundredDayAverageChangePercent": -0.47988608, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChangePercent": 13.295174, "regularMarketPrice": 0.3562, "marketState": "CLOSED", "shortName": "Vaxart, Inc. - Common Stock", "longName": "Vaxart, Inc.", "firstTradeDateMilliseconds": 376929000000, "postMarketChangePercent": -4.54801, "postMarketPrice": 0.34, "postMarketChange": -0.0162, "regularMarketChange": 0.041800022, "regularMarketDayRange": "0.3175 - 0.3599", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1838776, "postMarketTime": 1744415624, "regularMarketTime": 1744401600, "exchange": "NCM", "messageBoardId": "finmb_37819645", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Vaxart", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]